Abstract:Abstract Cardiac fibrosis, a well-known major pathological process that ultimately leads to heart failure, has attracted increasing attention and focus in recent years. A large amount of research indicates that long noncoding RNAs (lncRNAs) play an important role in cardiac fibrosis, but little is known about the specific function and mechanism of the lncRNA NEAT1 in the progression of cardiac fibrosis to heart failure. In the present study, we have demonstrated that the lncRNA NEAT1 is upregulated in patients with heart failure. Similarly, the expression of Neat1 was also increased in the left ventricular tissue of transverse aortic constriction (TAC) surgery mice and cardiac fibroblasts treated with TGF-β1. Further, gain-of-function and loss-of-function experiments showed that silencing of Neat1 attenuated cardiac fibrosis, while overexpression of Neat1 with adenovirus significantly aggravated the in vitro progression of fibrosis. With regard to the underlying mechanism, our experiments showed that Neat1 recruited EZH2 to the promoter region of Smad7 through physical binding of EZH2 to the promoter region, as a result of which Smad7 expression was inhibited and the progression of cardiac fibrosis was ultimately exacerbated. We found that the introduction of shNeat1 carried by adeno-associated virus-9 significantly ameliorated cardiac fibrosis and dysfunction caused by TAC surgery in mice. Overall, our study findings demonstrate that the lncRNA Neat1 accelerates the progression of cardiac fibrosis and dysfunction by recruiting EZH2 to suppress Smad7 expression. Thus, NEAT1 may serve as a target for the treatment of cardiac fibrosis.

The roles of long noncoding RNA NEAT1 in cardiovascular diseases

The Emerging Roles of Long Noncoding RNAs in Common Cardiovascular Diseases

The relationship between long non-coding RNA and cardiovascular development and diseases

Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases

The Roles of Long Noncoding RNAs in Myocardial Pathophysiology

The roles of long noncoding RNAs (lncRNAs) in myocardial pathophysiology.

Recent advances on the roles of LncRNAs in cardiovascular disease

The long non-coding RNA NEAT1 regulates the transcriptional landscape of cardiomyocytes

[Lncrnas and Cardiovascular Diseases].

Alterations of long noncoding RNAs and mRNAs in extracellular vesicles derived from the murine heart post-ischemia-reperfusion injury

Non-coding RNAs and angiogenesis in cardiovascular diseases: a comprehensive review

Long Noncoding RNA NEAT1 Promotes Myocardiocyte Apoptosis and Suppresses Proliferation Through Regulation of miR-129-5p

Long Noncoding RNA NEAT1 (nuclear Paraspeckle Assembly Transcript 1) is Critical for Phenotypic Switching of Vascular Smooth Muscle Cells.

Suppression of long noncoding RNA NEAT1 attenuates hypoxia-induced cardiomyocytes injury by targeting miR-378a-3p.

Neat1 Promotes Myocardial Ischemia-Reperfusion Injury Via Activating The Mapk Signaling Pathway

LncRNA NEAT1 in the pathogenesis of liver‐related diseases

Long Noncoding RNA: Genomics and Relevance to Physiology.

lncRNA NEAT1: key player in neurodegenerative diseases

Extracellular Non-Coding RNAs in Cardiovascular Diseases

The role of lncRNA MALAT1 in cardiovascular disease

Long noncoding RNA NEAT1 promotes cardiac fibrosis in heart failure through increased recruitment of EZH2 to the Smad7 promoter region